Galectin-3’s role in EMT is evident due to its ability to enhance tumor cell migration and proliferation, contribute to metalloprotease activity in the extracellular matrix, and alter integrin–collagen interactions [12,14,26]. This evidence concerns the gene LGALS3 and neoplasm.